{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:26:59Z","timestamp":1767432419798,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13793-4","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T11:36:05Z","timestamp":1764070565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assigning cancer stage to patients using administrative claims data: an example for colon and rectal cancers"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3667-4740","authenticated-orcid":false,"given":"Rebecca A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-0069","authenticated-orcid":false,"given":"Gebra","family":"Cuyun Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-6629","authenticated-orcid":false,"given":"Ifrah","family":"Fayyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreyah","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Ellenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley-Ann","family":"Miller-Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-5675","authenticated-orcid":false,"given":"Paul J.","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-9391","authenticated-orcid":false,"given":"Bruce","family":"Pyenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"13793_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. 2024. CA Cancer J Clin [Internet]. 2024;74:12\u201349. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"13793_CR2","unstructured":"American Cancer Society. American Cancer Society Releases Latest Cancer Statistics. Launches Initiative to Address Prostate Cancer Resurgence and Disparities [Internet]. 2023 [cited 2024 Feb 25]. Available from: American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities."},{"key":"13793_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","volume":"29","author":"AB Mariotto","year":"2020","unstructured":"Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29:1304\u201312.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13793_CR4","unstructured":"Centers for Disease Control and Prevention. Colorectal Cancer Statistics [Internet]. 2023 [cited 2023 Nov 30]. Available from: https:\/\/www.cdc.gov\/cancer\/colorectal\/statistics\/index.htm."},{"key":"13793_CR5","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"13793_CR6","doi-asserted-by":"crossref","unstructured":"Yabroff KR, Mariotto A, Tangka F, Zhao J, Islami F, Sung H, et al. Annual report to the Nation on the status of cancer, part 2: patient economic burden associated with cancer care. J Natl Cancer Inst. 2021;113:1670\u201382.","DOI":"10.1093\/jnci\/djab192"},{"key":"13793_CR7","unstructured":"American Cancer Society. Colorectal Cancer: Facts & Figs. 2023\u20132025, Atlanta GA. 2023. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/colorectal-cancer-facts-and-figures\/colorectal-cancer-facts-and-figures-2023.pdf."},{"key":"13793_CR8","doi-asserted-by":"publisher","unstructured":"McGarvey N, Gitlin M, Fadli E, Chung KC. Increased healthcare costs by later stage cancer diagnosis. BMC Health Serv Res [Internet]. 2022;22:1155. Available from: https:\/\/doi.org\/10.1186\/s12913-022-08457-6https:\/\/bmchealthservres.biomedcentral.com\/articles\/.","DOI":"10.1186\/s12913-022-08457-6"},{"key":"13793_CR9","doi-asserted-by":"publisher","unstructured":"Reddy SR, Broder MS, Chang E, Paydar C, Chung KC, Kansal AR. Cost of cancer management by stage at diagnosis among Medicare Beneficiaries. Curr Med Res Opin [Internet]. 2022;38:1285\u201394. Available from: https:\/\/doi.org\/10.1080\/03007995.2022.2047536.","DOI":"10.1080\/03007995.2022.2047536"},{"key":"13793_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.6004\/jnccn.2020.7799","volume":"20","author":"JH Lee","year":"2022","unstructured":"Lee JH, Mohamed T, Ramsey C, Kim J, Kane S, Gold KA, et al. A Hospital-Wide intervention to improve compliance with TNM cancer staging Documentation. JNCCN J Natl Compr Cancer Netw. 2022;20:351\u201360.","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"13793_CR11","first-page":"1","volume":"1","author":"S Brondfield","year":"2021","unstructured":"Brondfield S, Mulvey CK, Banerjee R, Velazquez AI, Kambhampati S, Parks AL, et al. Got stage fright? A Fellow-Led initiative to improve cancer staging Documentation. Int J Cancer Care Delivery. 2021;1:1\u20135.","journal-title":"Int J Cancer Care Delivery"},{"key":"13793_CR12","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1200\/JOP.2015.004622","volume":"12","author":"JL Warner","year":"2016","unstructured":"Warner JL, Levy MA, Neuss MN. Feasibility and accuracy of extracting cancer stage information from narrative electronic health record data. J Oncol Pract. 2016;12:e169\u201379.","journal-title":"J Oncol Pract"},{"key":"13793_CR13","unstructured":"Division of Cancer Control and Population Sciences (DCCPS). SEER-medicare linked data resource. Washington, DC; 2023."},{"key":"13793_CR14","doi-asserted-by":"publisher","unstructured":"Yarden R, Newcomer KL. Young-onset colorectal cancer patients disproportionately diagnosed with advanced disease: patient self-reported journey of symptom duration and misdiagnosis. J Clin Oncol [Internet]. 2019;37:3567\u20133567. Available from: https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.3567.","DOI":"10.1200\/JCO.2019.37.15_suppl.3567"},{"key":"13793_CR15","doi-asserted-by":"publisher","first-page":"e2300003","DOI":"10.1200\/cci.23.00003","volume":"7","author":"CB Finn","year":"2023","unstructured":"Finn CB, Sharpe JE, Tong JK, et al. Development of a machine learning model to identify colorectal cancer stage in medicare claims. JCO Clin Cancer Inf. 2023;7:e2300003. https:\/\/doi.org\/10.1200\/cci.23.00003.","journal-title":"JCO Clin Cancer Inf"},{"key":"13793_CR16","doi-asserted-by":"publisher","unstructured":"Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov. 2010;7:1. Published 2010 Jan 15. https:\/\/doi.org\/10.1186\/1742-5573-7-1.","DOI":"10.1186\/1742-5573-7-1"},{"key":"13793_CR17","doi-asserted-by":"crossref","unstructured":"Brooks GA, Bergquist SL, Landrum MB, Rose S, Keating NL. Classifying stage IV lung cancer from health care claims: a comparison of multiple analytic approaches. JCO Clin Cancer Inf. 2019:1\u201319.","DOI":"10.1200\/CCI.18.00156"},{"key":"13793_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2016.00018","volume":"6","author":"BL Nordstrom","year":"2016","unstructured":"Nordstrom BL, Simeone JC, Malley KG, Fraeman KH, Klippel Z, Durst M, et al. Validation of claims algorithms for progression to metastatic cancer in patients with breast, non-small cell lung, and colorectal cancer. Front Oncol. 2016;6:1\u20139.","journal-title":"Front Oncol"},{"key":"13793_CR19","volume-title":"R: A Language and environment for statistical computing","author":"R Core Team","year":"2021","unstructured":"R Core Team. R: A Language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021."},{"key":"13793_CR20","first-page":"183","volume-title":"Generalized linear Models. Modern applied statistics with S","author":"WN Venables","year":"2002","unstructured":"Venables WN, Ripley BD. Generalized linear Models. Modern applied statistics with S. New York, NY: Springer US; 2002. pp. 183\u2013210."},{"key":"13793_CR21","unstructured":"Milliman Inc. Life sciences data assets [Internet]. [cited 2023 Dec 4]. Available from: https:\/\/us.milliman.com\/en\/health\/life-sciences\/data-assets."},{"key":"13793_CR22","doi-asserted-by":"publisher","unstructured":"Oppelt KA, Luttmann S, Kraywinkel K, Haug U. Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data. BMC Med Res Methodol [Internet]. 2019;19:142. Available from: https:\/\/doi.org\/10.1186\/s12874-019-0784-yhttps:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/.","DOI":"10.1186\/s12874-019-0784-y"},{"key":"13793_CR23","doi-asserted-by":"crossref","unstructured":"Quantin C, Benzenine E, H\u00e4gi M, Auverlot B, Abrahamowicz M, Cottenet J, et al. Estimation of national colorectal-cancer incidence using claims databases. J Cancer Epidemiol [Internet]. 2012;2012:1\u20137. Available from: http:\/\/www.hindawi.com\/journals\/jce\/2012\/298369\/.","DOI":"10.1155\/2012\/298369"},{"key":"13793_CR24","doi-asserted-by":"publisher","unstructured":"Hirano T, Negishi M, Kuwatsuru Y, Arai M, Wakabayashi R, Saito N, et al. Validation of algorithms to identify colorectal cancer patients from administrative claims data of a Japanese hospital. BMC Health Serv Res [Internet]. 2023;23:274. Available from: https:\/\/doi.org\/10.1186\/s12913-023-09266-1https:\/\/bmchealthservres.biomedcentral.com\/articles\/.","DOI":"10.1186\/s12913-023-09266-1"},{"key":"13793_CR25","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/MLR.0b013e318289c3fb","volume":"53","author":"JL Whyte","year":"2015","unstructured":"Whyte JL, Engel-Nitz NM, Teitelbaum A, Gomez Rey G, Kallich JD. An evaluation of algorithms for identifying metastatic breast, lung, or colorectal cancer in administrative claims data. Med Care. 2015;53:e49\u201357.","journal-title":"Med Care"},{"key":"13793_CR26","doi-asserted-by":"publisher","unstructured":"Finn CB, Sharpe JE, Tong JK, Kaufman EJ, Wachtel H, Aarons CB, et al. Development of a machine learning model to identify colorectal cancer stage in Medicare claims [Internet]. JCO Clin Cancer Inform. 2023. Available from: https:\/\/doi.org\/10.1200\/CCI.23.00003.","DOI":"10.1200\/CCI.23.00003"},{"key":"13793_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1186\/s12913-022-08457-6","volume":"22","author":"N McGarvey","year":"2022","unstructured":"McGarvey N, Gitlin M, Fadli E, Chung KC. Increased healthcare costs by later stage cancer diagnosis. BMC Health Serv Res. 2022;22:1155.","journal-title":"BMC Health Serv Res"},{"key":"13793_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/03007995.2022.2047536","volume":"38","author":"SR Reddy","year":"2022","unstructured":"Reddy SR, Broder MS, Chang E, Paydar C, Chung KC, Kansal AR. Cost of cancer management by stage at diagnosis among medicare beneficiaries. Curr Med Res Opin. 2022;38:1285\u201394.","journal-title":"Curr Med Res Opin"},{"key":"13793_CR29","unstructured":"Lopez E, Neuman T, Jacobson G, Levitt L. How much more than Medicare do private insurers pay? A review of the literature. Washington, D.C. 2020."},{"key":"13793_CR30","first-page":"70","volume":"14","author":"S Tomicki","year":"2021","unstructured":"Tomicki S, Dieguez G, Latimer H, Cockrum P, Kim G. Real-World cost of care for commercially insured versus medicare patients with metastatic pancreatic cancer who received Guideline-Recommended therapies. Am Health Drug Benefits. 2021;14:70\u20138.","journal-title":"Am Health Drug Benefits"},{"key":"13793_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-3284-4-15","volume":"4","author":"JJ Jacobson","year":"2012","unstructured":"Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, et al. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid. Head Neck Oncol. 2012;4:15.","journal-title":"Head Neck Oncol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13793-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:22:48Z","timestamp":1767432168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-13793-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13793"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13793-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The WIRB-Copernicus Group (WCG) IRB reviewed our study (Sponsor Protocol No.: 4500062855) under the Common Rule and applicable guidance and declared it exempt from IRB review under 45 CFR \u00a7\u00a046.104(d)(4). WCG IRB is registered with FDA\/OHRP. WCG IRB registration number is IRB00000533, and WCG IRB\u2019s parent organization number is IORG0000432. WCG IRB reviewed our research in accordance with The Health and Human Services (HHS) Regulations on research with human beings (45 CFR 46 Subparts A, B, C, and D), as it used SEER registry data obtained from the National Cancer Institute. The HHS regulations apply to research that is funded by or use assets from HHS or other institutions that have adopted \u201cthe Common Rule,\u201d represented at 45 CFR 46, Subpart A. The exemption letter can be provided to the Editor upon request. Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate was deemed unnecessary by the WCG IRB under the Common Rule and applicable guidance under 45 CFR \u00a7\u00a046.104(d)(4). WCG IRB is registered with FDA\/OHRP. WCG IRB registration number is IRB00000533, and WCG IRB\u2019s parent organization number is IORG0000432. WCG IRB reviewed our research in accordance with The Health and Human Services (HHS) Regulations on research with human beings (45 CFR 46 Subparts A, B, C, and D), as it used SEER registry data obtained from the National Cancer Institute. The HHS regulations apply to research that is funded by or use assets from HHS or other institutions that have adopted \u201cthe Common Rule,\u201d represented at 45 CFR 46, Subpart A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was funded by Exact Sciences Corporation, and some of the authors are employed by (or were previously employed by) Exact Sciences.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}